Shares of Proteome Sciences plc (LON:PRM – Get Free Report) rose 9% during mid-day trading on Monday . The stock traded as high as GBX 3.91 ($0.05) and last traded at GBX 3.35 ($0.04). Approximately 967,070 shares changed hands during trading, an increase of 496% from the average daily volume of 162,146 shares. The stock had previously closed at GBX 3.07 ($0.04).
Proteome Sciences Trading Up 3.5 %
The company has a market cap of £9.65 million, a PE ratio of -327.00 and a beta of 0.07. The firm has a 50 day moving average of GBX 2.73 and a two-hundred day moving average of GBX 3.15.
About Proteome Sciences
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Featured Stories
- Five stocks we like better than Proteome Sciences
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Top 3 Reasons to Invest in This Bond ETF for Stability and Growth
- Insider Trading – What You Need to Know
- 2 Drone Stocks Surging from Increased Media Attention
- How to Capture the Benefits of Dividend Increases
- Ciena Rebounds: AI and Strong Guidance Drive Post-Earnings Surge
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
